Search results: Sage Journals

Available accessReview articleFirst published November, 2013

Ponatinib

Caitlin L. Shamroe, Jill M. Comeau

Annals of Pharmacotherapy

Open accessResearch articleFirst published January, 2015

Cost-effectiveness of ponatinib in chronic myeloid leukemia in Italy

Carlo Lucioni, Sergio Iannazzo, Silvio Mazzi [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open accessCase reportFirst published April, 2020

A patient with maculopapular rash and lichenoid skin damage caused by ponatinib

Ingrid Anna Teigen, Anna Kristine Myrmel Sæle, Håkon Reikvam

Journal of International Medical Research

Open accessReview articleFirst published 2019

Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia

Matteo Molica, Emilia Scalzulli, Gioia Colafigli [...]

Therapeutic Advances in Hematology

Open accessCase reportFirst published 2025

A case of pityriasis rubra pilaris secondary to ponatinib

Ariana Nateghi, Florence Lagacé-Thomassin, Julie Desrochers

Sage Open Medical Case Reports

Open accessResearch articleFirst published 2023

Comparison of the Efficacy and Safety of Ponatinib and Dasatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Central Nervous System Relapse: A Retrospective Study

Yuanxin Zhu, Ying Zhu, Lei Miao [...]

Technology in Cancer Research & Treatment

Available accessResearch articleFirst published March, 2020

Erythema Annulare Centrifugum in a Patient with Chronic Myeloid Leukaemia on Ponatinib

Kripa Maharjan, Sudeep Adhikari, Amit Amatya [...]

Journal of the Royal College of Physicians of Edinburgh

Available accessResearch articleFirst published April, 2024

Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells

Burcin Tezcanli Kaymaz, Nurcan Gumus, Besne Celik [...]

Journal of Interferon & Cytokine Research

Available accessResearch articleFirst published August, 2013

Drug Monographs: Pomalidomide and Ponatinib

Taylor W. Butler, J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Open accessCase reportFirst published 2026

Successful Management of Tyrosine Kinase Inhibitor-Induced Bone Marrow Aplasia in Chronic Phase Chronic Myeloid Leukemia with Ponatinib: A Case Report and Literature Review

Rola Ghasoub, Laila Shafei, Ruba Y. Taha [...]

Clinical Medicine Insights: Case Reports

Available accessReview articleFirst published November, 2013

Ponatinib

Caitlin L. Shamroe, Jill M. Comeau

Annals of Pharmacotherapy

Open accessResearch articleFirst published January, 2015

Cost-effectiveness of ponatinib in chronic myeloid leukemia in Italy

Carlo Lucioni, Sergio Iannazzo, Silvio Mazzi [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open accessCase reportFirst published April, 2020

A patient with maculopapular rash and lichenoid skin damage caused by ponatinib

Ingrid Anna Teigen, Anna Kristine Myrmel Sæle, Håkon Reikvam

Journal of International Medical Research

Open accessReview articleFirst published 2019

Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia

Matteo Molica, Emilia Scalzulli, Gioia Colafigli [...]

Therapeutic Advances in Hematology

Open accessCase reportFirst published 2025

A case of pityriasis rubra pilaris secondary to ponatinib

Ariana Nateghi, Florence Lagacé-Thomassin, Julie Desrochers

Sage Open Medical Case Reports

Open accessResearch articleFirst published 2023

Comparison of the Efficacy and Safety of Ponatinib and Dasatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Central Nervous System Relapse: A Retrospective Study

Yuanxin Zhu, Ying Zhu, Lei Miao [...]

Technology in Cancer Research & Treatment

Available accessResearch articleFirst published March, 2020

Erythema Annulare Centrifugum in a Patient with Chronic Myeloid Leukaemia on Ponatinib

Kripa Maharjan, Sudeep Adhikari, Amit Amatya [...]

Journal of the Royal College of Physicians of Edinburgh

Available accessResearch articleFirst published April, 2024

Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells

Burcin Tezcanli Kaymaz, Nurcan Gumus, Besne Celik [...]

Journal of Interferon & Cytokine Research

Available accessResearch articleFirst published August, 2013

Drug Monographs: Pomalidomide and Ponatinib

Taylor W. Butler, J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Open accessCase reportFirst published 2026

Successful Management of Tyrosine Kinase Inhibitor-Induced Bone Marrow Aplasia in Chronic Phase Chronic Myeloid Leukemia with Ponatinib: A Case Report and Literature Review

Rola Ghasoub, Laila Shafei, Ruba Y. Taha [...]

Clinical Medicine Insights: Case Reports